XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.20.2

Note 6 - Restructuring and Other Exit Costs | 9 Months Ended
--- | ---
Sep. 30, 2020
Notes to Financial Statements |
Restructuring and Related Activities Disclosure [Text Block] |
6. | Restructuring and Other Exit Costs
On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify operational efficiencies, enhance commercial capabilities and align its cost base and infrastructure with customer needs and its strategic plans. In order to realize these opportunities, the Company undertakes restructuring-type activities from time to time to transform its business. The following tables summarize restructuring and other exit charges for the periods set forth below:
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
(in thousands) |  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Cost of revenues |  | $ | - |  |  | $ | 235 |  |  | $ | - |  |  | $ | 235 |
Severance costs |  |  | 234 |  |  |  | 209 |  |  |  | 1,585 |  |  |  | 209 |
Impairment charges |  |  | - |  |  |  | 460 |  |  |  | - |  |  |  | 460 |
Other |  |  | 85 |  |  |  | 10 |  |  |  | 310 |  |  |  | 10 |
Restructuring and other exit costs |  | $ | 319 |  |  | $ | 914 |  |  | $ | 1,895 |  |  | $ | 914 |
The following table summarizes the changes in the restructuring liabilities for the nine months ended September 30, 2020:
(in thousands) |  | Severance |  |  | Other |  |  | Total |
Balance at December 31, 2019 |  | $ | 364 |  |  | $ | 4 |  |  | $ | 368 |
Restructuring and other exit costs |  |  | 1,585 |  |  |  | 310 |  |  |  | 1,895 |
Non-cash charges |  |  | - |  |  |  | (168 | ) |  |  | (168 | )
Cash payments |  |  | (1,370 | ) |  |  | (117 | ) |  |  | (1,487 | )
Balance at September 30, 2020 |  | $ | 579 |  |  | $ | 29 |  |  | $ | 608 |
During the nine months ended September 30, 2019, the Company incurred impairment charges of $1.4 million consisting of pre-restructuring plan charges of $0.9 million to write-off certain in-process research and development intangible assets, and restructuring plan charges of $0.5 million to write-off certain intangible assets as a result of a decision to discontinue a product line and cease operations in its facility in North Carolina. As of September 30, 2020, the Company had a restructuring liability of $0.6 million which is payable within the next twelve months and has been included in other current liabilities in the consolidated balance sheet.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -URI http://asc.fasb.org/topic&trid=2175745 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration